Skip to main content
. Author manuscript; available in PMC: 2021 Aug 3.
Published in final edited form as: J Adv Nurs. 2019 Aug 7;75(11):3045–3057. doi: 10.1111/jan.14142

TABLE 1.

Demographics variable analysis

Variable Total (N = 410) Control group (N = 204) Intervention group (N = 206) p value
Age, mean (SD) 58.6 (18.9) 57.4 (19.2) 59.8 (18.6) .188a
ETT type, n (%)
 SS-ETT 349 (85.1) 171 (83.8) 178 (86.4) .462a
 Conventional ETT 61 (14.9) 33 (16.2) 28 (13.6)
Gender, n (%)
 Male 242 (59.0) 118 (57.8) 124 (60.2) .628a
 Female 168 (41.0) 86 (42.2) 82 (39.8)
Race, n (%)
 White 304 (74.1) 149 (73.0) 155 (75.2) .541a
 Black 86 (21.0) 44 (21.6) 42 (20.4)
 Asian 18 (4.4) 9 (4.4) 9 (4.4)
 Other 2 (0.5) 2 (1.0) 0 (0)
Ethnicity, n (%)
 Not Hispanic or Latino 334 (81.5) 169 (82.8) 165 (80.1) .474a
 Hispanic or Latino 76 (18.5) 35 (17.2) 41 (19.9)
Diagnoses, n (%)
 Medical and surgical 151 (36.8) 66 (32.4) 85 (41.3) .173a
 Trauma 121 (29.5) 62 (30.4) 59 (28.6)
 Neurological 120 (29.3) 64 (31.4) 56 (27.2)
Comorbidities, n (%)
 Diabetes 103 (25.1) 56 (27.5) 47 (22.8) .279a
 History of smoking 95 (23.2) 43 (21.1) 52 (25.2) .318a
 Chronic heart failure 49 (12.0) 24 (11.8) 25 (12.1) .908a
 Chronic renal failure 43 (10.5) 21 (10.3) 22 (10.7) .899a
 History of ETOH abuse 41 (10.0) 18 (8.8) 23 (11.2) .429a
 COPD 33 (8.0) 17 (8.3) 16 (7.8) .833a
 History of drug abuse 27 (6.6) 13 (6.4) 14 (6.8) .863a
 Immune-com-promise 10 (2.4) 5 (2.5) 5 (2.4) .988a
 Chronic liver failure 8 (2.0) 4 (2.0) 4 (1.9) .989a
Acuity, mean (SD)
 APACHE II 23.3 (7.5) 22.7 (0.5) 23.0 (0.5) .691b
 SAPS 48.9 (15.5) 47.8 (1.0) 48.3 (0.9) .742b
 ISS trauma only 23.7 (11.0) 21.9 (1.2) 24.2 (1.4) .217b

Note: Abbreviations: APACHE, acute physiology and chronic health evaluation; COPD, chronic obstructive pulmonary disease; ETOH, alcohol; ETT, endotracheal tube; ISS, Injury Severity Score; SAPS, Simplified Acute Physiology Score; SD, standard deviation.

a

Chi-Square.

b

t-test.